Amgen Announces New Data Highlighting Global Trends In Hip Fracture Incidence And Treatment Biotech Investing
BioHarvest Sciences Inc Announces the Closing of Its Previously Announced Private Placement and the Amount Raised from Exercise of Warrants Biotech Investing
AbbVie to Showcase New Data at the United European Gastroenterology Week Virtual 2021 Biotech Investing
Amgen And Kyowa Kirin Present Positive Late-Breaking Data From Phase 2 Study Of AMG 451/KHK4083 In Adult Patients With Moderate-to-Severe Atopic Dermatitis At EADV Congress Biotech Investing
U.S. FDA Approves Kite's Tecartus® as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Biotech Investing
European Medicines Agency Validates Bristol Myers Squibb's Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as First-Line Treatment for Patients with Unresectable or Metastatic Melanoma Biotech Investing
European Medicines Agency Validates Bristol Myers Squibb's Application for Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy Biotech Investing
Kite Submits Supplemental Biologics License Application to U.S. Food and Drug Administration for Earlier Use of Yescarta® in Large B-cell Lymphoma Biotech Investing
